GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Holdings Corp (XKRX:001630) » Definitions » EV-to-EBIT

Chong Kun Dang Holdings (XKRX:001630) EV-to-EBIT : 4.25 (As of May. 20, 2024)


View and export this data going back to 1976. Start your Free Trial

What is Chong Kun Dang Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Chong Kun Dang Holdings's Enterprise Value is ₩675,368 Mil. Chong Kun Dang Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩159,015 Mil. Therefore, Chong Kun Dang Holdings's EV-to-EBIT for today is 4.25.

The historical rank and industry rank for Chong Kun Dang Holdings's EV-to-EBIT or its related term are showing as below:

XKRX:001630' s EV-to-EBIT Range Over the Past 10 Years
Min: -71.19   Med: 8.46   Max: 815.93
Current: 10.67

During the past 13 years, the highest EV-to-EBIT of Chong Kun Dang Holdings was 815.93. The lowest was -71.19. And the median was 8.46.

XKRX:001630's EV-to-EBIT is ranked better than
72.71% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.86 vs XKRX:001630: 10.67

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Chong Kun Dang Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was ₩545,070 Mil. Chong Kun Dang Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩159,015 Mil. Chong Kun Dang Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 29.17%.


Chong Kun Dang Holdings EV-to-EBIT Historical Data

The historical data trend for Chong Kun Dang Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Holdings EV-to-EBIT Chart

Chong Kun Dang Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.29 7.12 27.21 -62.85 14.68

Chong Kun Dang Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 467.14 37.49 20.36 14.68 -

Competitive Comparison of Chong Kun Dang Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chong Kun Dang Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Holdings's EV-to-EBIT falls into.



Chong Kun Dang Holdings EV-to-EBIT Calculation

Chong Kun Dang Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=675368.396/159014.685
=4.25

Chong Kun Dang Holdings's current Enterprise Value is ₩675,368 Mil.
Chong Kun Dang Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩159,015 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chong Kun Dang Holdings  (XKRX:001630) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Chong Kun Dang Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=159014.685/545070.136
=29.17 %

Chong Kun Dang Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was ₩545,070 Mil.
Chong Kun Dang Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩159,015 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chong Kun Dang Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Chong Kun Dang Holdings (XKRX:001630) Business Description

Traded in Other Exchanges
N/A
Address
368, 3-ga, Choongjungro, Suhdaemoon-gu, Seoul, KOR, 120-756
Chong Kun Dang Holdings Corp manufactures and markets medicines and active pharmaceutical ingredients. It offers prescription drugs; over-the-counter pharmaceutical products; health supplements and consumer health products. Geographically activities are functioned through the region of South Korea.

Chong Kun Dang Holdings (XKRX:001630) Headlines

No Headlines